检验医学 ›› 2016, Vol. 31 ›› Issue (8): 671-674.DOI: 10.3969/j.issn.1673-8640.2016.08.008

• 临床应用研究·论著 • 上一篇    下一篇

CML患者TGF-β1 mRNA与bcr/ablP210融合基因转录本表达的关系

许大兵, 孙余婕, 沈佐君   

  1. 安徽医科大学附属省立医院 安徽省临床检验中心,安徽 合肥 230001
  • 收稿日期:2016-03-07 出版日期:2016-08-31 发布日期:2016-09-01
  • 作者简介:null

    作者简介:许大兵,男,1980年生,学士,主管技师,主要从事临床检验工作。

    通讯作者:沈佐君,联系电话:0551-62283847。

  • 基金资助:
    国家自然科学基金项目(30672011);安徽省卫生厅医学课题(13cz026)

Relationship between TGF-β1 mRNA and bcr/ablP210 fusion gene transcription expression levels in CML patients

XU Dabing, SUN Yujie, SHEN Zuojun   

  1. Anhui Provincial Hospital,Anhui Medical University/Anhui Provincial Center for Clinical Laboratories,Hefei 230001,Anhui,China
  • Received:2016-03-07 Online:2016-08-31 Published:2016-09-01

摘要:

目的 通过分析慢性粒细胞白血病(CML)患者转化生长因子-β1(TGF-β1)mRNA与bcr/ablP210融合基因转录本(简称bcr/ablP210)的表达水平,探讨两者在CML发病过程中可能的作用。方法 采用实时荧光定量聚合酶链反应(PCR)检测73例CML患者外周血和骨髓中TGF-β1 mRNA及bcr/ablP210的表达水平,以22名健康体检者作为正常对照组。TGF-β1 mRNA与bcr/ablP210的相关性采用Pearson相关分析。结果 CML患者骨髓和外周血样本中TGF-β1 mRNA、bcr/ablP210的表达水平差异无统计学意义(P>0.05)。正常对照组外周血中TGF-β1 mRNA的表达水平明显高于CML患者骨髓中TGF-β1 mRNA的表达水平(P<0.05),正常对照组TGF-β1 mRNA的表达水平是CML组的11.39倍。相关性分析显示CML患者TGF-β1 mRNA与bcr/ablP210呈正相关(r=0.53,P<0.01)。结论 骨髓TGF-β1 mRNA有可能作为一种新的CML诊疗指标。

关键词: 转化生长因子-β1, bcr/ablP210, 融合基因, 转录本

Abstract:

Objective To investigate the possible pathogenesis of chronic myelogenous leukemia(CML) by analyzing the expression levels of transforming growth factor-beta 1(TGF-β1) mRNA and bcr/ablP210 fusion gene transcription in patients with CML.Methods Real-time fluorescence quantitative polymerase chain reaction(PCR) was used to determine the expression levels of TGF-β1 mRNA and bcr/ablP210 in peripheral blood and bone marrow of 73 patients with CML. A total of 22 healthy subjects were enrolled as healthy control group. Pearson correlation analysis was used to analyze the correlation of TGF-β1 mRNA and bcr/ablP210. Results The expression levels of TGF-β1 mRNA and bcr/ablP210 in peripheral blood and bone marrow of patients with CML had no statistical significance(P>0.05). The expression levels of TGF-β1 mRNA in healthy control group were higher for 11.39 times than those in CML group(P<0.05). The expression levels of TGF-β1 mRNA and bcr/ablP210 had a positive correlation in CML group(r=0.53,P<0.01). Conclusions TGF-β1 mRNA in bone marrow may be a new indicator for the diagnosis and treatment of CML.

Key words: Transforming growth factor-beta 1, bcr/ablP210, Fusion gene, Transcription

中图分类号: